All In Biotech

Drug Trial Radar · NCT02404103

Flunisolide HFA in Children With Small Airway Disease

Last checked: Nov 20, 2026Latest source record: Dec 14, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

26

Actual

Start

Mar 2015

Primary completion

May 2017

Study completion Jun 2017

Sponsor

Lead sponsor
University of LouisvilleAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Meda Pharmaceuticals
First posted
Mar 31, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 6 years, up to 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to see how two doses of Flunisolide HFA (an FDA approved inhaled medication to treat asthma) affect the small airways in children with asthma.

Conditions

  • Childhood Asthma

Interventions

  • Flunisolide HFADrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Spirometry Forced Expiratory Volume 1 (FEV1) After FlunisolideTime frame: Before and after treatment at baseline and six week followup
  2. Impulse Oscillometry (IOS) Area of Reactance (AX) After Flunisolide TreatmentTime frame: Baseline and six week followup
  3. Spirometry Forced Expiratory Flow 25-75% (FEF 25-75%)Time frame: baseline and six week followup
  4. Impulse Oscillometry (IOS) Resistance 5 (R5)Time frame: initial visit and six week followup

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University of Louisville Pediatric Pulmonology

    Louisville, Kentucky

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.